China’s State Administration for Market Regulation (SAMR) has conditionally approved Synopsys’ (NASDAQ:SNPS) acquisition of Ansys (NASDAQ:ANSS), marking a critical step forward for the $35-billion deal in one of the companies’ key markets.
The regulatory greenlight comes with restrictions aimed at preserving competition:
Synopsys cannot terminate existing contracts with Chinese customers.
It must honor renewal requests from these customers.
These measures are designed to ensure continuous access to critical design software in China’s electronics and semiconductor industries.
China is a major market for both Synopsys and Ansys. Regulatory approval from SAMR was one of the final international hurdles before the deal could close. The move underscores how antitrust reviews are increasingly influencing large-cap tech mergers with global footprints.
To track acquisition activity like this—especially those that affect valuation and strategy—you can use the Company Rating API. It combines fundamental data and analyst ratings to offer a real-time snapshot of a firm’s quality and market positioning.
With U.S. and EU regulators already having cleared the deal, China’s conditional approval signals the transaction could close within 2025. Investors are watching whether customer retention in China becomes a long-term operational challenge post-merger.
For deeper insight into M&A-driven performance shifts, use the Bulk Ratings API to scan for analyst rating changes across multiple tickers simultaneously, including Synopsys and Ansys.
